Scientific Background & Industry Challenge

Under the global transition toward antimicrobial stewardship and green agriculture, intensive poultry, livestock, and aquaculture operations face dual pressures: stringent regulatory thresholds prohibiting non-therapeutic antibiotic usage, and widespread emergence of multidrug-resistant (MDR) bacterial pathotypes. Traditional chemical interventions non-specifically destroy the host microbiome, causing recurrent mucosal dysbiosis and secondary infections.

Core Mechanism & Technical Innovation

Bacteriophages represent nature's precision antibacterial agents. By recognizing specific outer membrane lipopolysaccharides (LPS) or outer membrane proteins (OMPs), virulent phages inject genomic material, replicate logarithmically within target cells, and express lytic endolysins and holins to cause osmotic lysis. This mode of action ensures absolute host specificity—sparing commensal Lactobacillus and Bifidobacterium species while maintaining zero chemical residue in meat, eggs, and milk.

Newline Bio's proprietary "Three Libraries, One Platform, and One System" framework establishes a continuously updated biobank of over 10,000 characterized lytic phages. Through comprehensive genomics and high-throughput host range profiling, cocktail formulations are dynamically tuned against shifting field epidemiology to prevent resistance emergence.

Practical Farm Application & Strategic Outcomes

Clinical trials and extensive on-farm validation verify that implementing tailored phage protocols—via early drinking water administration, fine aerosol misting in barns, or feed incorporation—dramatically suppresses pathogen loads. Field data demonstrate log-scale reductions in shedding, marked improvements in flock and herd uniformity, lower feed conversion ratios (FCR), and complete avoidance of drug withdrawal penalties.